A Randomize, Placebo-controlled, Crossover Study to Measure the Effect of Alosetron on Mucosal Blood Flow in Female Healthy Volunteers and Diarrhea-predominant IBS Subjects
Phase of Trial: Phase IV
Latest Information Update: 22 May 2015
At a glance
- Drugs Alosetron (Primary)
- Indications Irritable bowel syndrome
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 08 Apr 2009 Actual patient number (49) added as reported by ClinicalTrials.gov.
- 15 Oct 2008 Actual start date changed from Nov 2006 to Dec 2006 as reported by ClinicalTrials.gov.
- 04 Apr 2008 Status changed from recruiting to completed, according to ClinicalTrials.gov.